Johnson & Johnson Share Price Lima

Equities

JNJ

US4781601046

Pharmaceuticals

End-of-day quote Lima 03:30:00 26/06/2024 am IST 5-day change 1st Jan Change
146.4 USD -0.46% Intraday chart for Johnson & Johnson -0.46% -4.75%
Sales 2024 * 88.75B 7,404B Sales 2025 * 92.27B 7,699B Capitalization 353B 29,481B
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 3.98 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 3.83 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 1,31,900
Yield 2024 *
3.31%
Yield 2025 *
3.46%
Free-Float 77.08%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.61%
1 week-0.46%
Current month-0.46%
1 month+1.31%
3 months-9.59%
6 months-4.75%
Current year-4.75%
More quotes
1 week
146.40
Extreme 146.4
147.07
1 month
144.51
Extreme 144.51
147.50
Current year
144.51
Extreme 144.51
161.93
1 year
144.51
Extreme 144.51
166.00
3 years
144.51
Extreme 144.51
186.00
5 years
112.00
Extreme 112
186.00
10 years
112.00
Extreme 112
186.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 01/89/01
Director of Finance/CFO 57 01/98/01
Chief Tech/Sci/R&D Officer 58 05/19/05
Members of the board TitleAgeSince
Director/Board Member 70 25/19/25
Director/Board Member 72 19/14/19
Director/Board Member 70 22/09/22
More insiders
Date Price Change
26/24/26 146.4 -0.46%
25/24/25 147.1 0.00%
24/24/24 147.1 0.00%
21/24/21 147.1 0.00%
20/24/20 147.1 0.00%

End-of-day quote Lima, June 26, 2024

More quotes
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
146.8 USD
Average target price
171.7 USD
Spread / Average Target
+16.96%
Consensus